You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 21, 2025

Details for Patent: 8,530,668


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,530,668 protect, and when does it expire?

Patent 8,530,668 protects MULPLETA and is included in one NDA.

This patent has twenty-six patent family members in twenty countries.

Summary for Patent: 8,530,668
Title:Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity, and intermediate therefor
Abstract: An optically active 4-phenylthiazole derivative having a thrombopoietin receptor agonist activity and a pharmaceutical composition containing the present compound as an active ingredient are created, and a platelet production regulating agent which can be orally administered is provided. Disclosed is a pharmaceutical composition containing, as an active ingredient, an optically active compound represented by the formula: ##STR00001## wherein, R.sup.1 is a halogen atom or C1-C3 alkyloxy; R.sup.2 is C1-C8 alkyl; R.sup.3 is C1-C8 alkyl; R.sup.4 and R.sup.5 are each independently a fluorine atom or chlorine atom; R.sup.6 is C1-C3 alkyl or C1-C3 alkyloxy; * indicates that a carbon atom marked with an asterisk is an asymmetric carbon, a pharmaceutically acceptable salt thereof, or a solvate thereof.
Inventor(s): Takayama; Masami (Osaka, JP), Kurose; Noriyuki (Osaka, JP)
Assignee: Shionogi & Co., Ltd. (Osaki-Shi, Osaka, JP)
Application Number:12/671,476
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,530,668

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 8,530,668, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 8,530,668 was granted on September 10, 2013. To analyze this patent, we need to look at its title, abstract, and the detailed description of its claims.

Title and Abstract

  • Title: The title of the patent provides a brief summary of the invention. For example, if the patent is titled "Method and System for [Specific Invention]," it sets the stage for what the patent covers.
  • Abstract: The abstract is a concise summary of the invention, including its main features and advantages. It gives a quick overview of what the patent is about.

Claims

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are the broadest claims in the patent and set the boundaries of what is protected.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They narrow down the scope of the invention and often add specific details or features.

Claim Analysis

To analyze the claims of US Patent 8,530,668, one would typically:

  • Identify the independent claims to understand the broadest scope of the invention.
  • Examine the dependent claims to see how they further define and limit the invention.
  • Look for any specific limitations or requirements within the claims that could affect the patent's enforceability or scope.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial in patent litigation and can significantly impact the scope of the patent. The courts use various tools, including the patent specification, prosecution history, and extrinsic evidence, to construe the claims[5].

Scope of the Patent

Patent Scope Measurements

The scope of a patent can be measured using various metrics, such as those provided in the Patent Claims Research Dataset by the USPTO. This dataset includes detailed information on claims from U.S. patents and can help in understanding the breadth and depth of patent claims[3].

Patent Family and Global Dossier

  • Patent Family: The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices. This helps in understanding the global scope and coverage of the patent[1].
  • Global Dossier: This service also provides access to the file histories, classification, and citation data for these applications, giving a comprehensive view of the patent's international scope.

Patent Landscape

Prior Art and Citation Data

  • Common Citation Document (CCD): The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This helps in understanding how the patent fits into the broader landscape of prior art and related inventions[1].

Competitors and Related Patents

Analyzing the patent landscape involves identifying competitors and related patents. This can be done by searching through patent databases, such as the USPTO's Public Search Facility or Patent and Trademark Resource Centers (PTRCs), to find similar patents and understand the competitive environment[1].

Legal and Practical Considerations

Patent Litigation

In cases of patent litigation, such as the example of VLSI Technology LLC v. Intel Corporation, the scope and claims of the patent are critically examined. The courts review the evidence supporting the claims and the construction of those claims to determine infringement and damages[5].

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could potentially impact the enforcement and scope of patents. Such a court would aim to provide a more streamlined and cost-effective process for resolving patent disputes, which could affect how patent claims are litigated and enforced[2].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is essential for determining the scope of the patent.
  • Patent Scope Measurements: Using datasets and tools provided by the USPTO can help in quantifying the breadth and depth of patent claims.
  • Global Dossier: This service provides a comprehensive view of the patent's international scope and related applications.
  • Prior Art and Citation Data: The CCD application helps in understanding the patent's position within the broader landscape of prior art.
  • Legal Considerations: Patent litigation and potential reforms like a small claims patent court can significantly impact the enforcement and scope of patent claims.

FAQs

What is the importance of claim construction in patent litigation?

Claim construction is crucial in patent litigation as it determines the scope of the patent and can significantly impact the outcome of infringement cases.

How can the Global Dossier service help in understanding a patent's scope?

The Global Dossier service provides access to the file histories, classification, and citation data for related applications, giving a comprehensive view of the patent's international scope.

What is the Common Citation Document (CCD) and its significance?

The CCD consolidates prior art cited by all participating offices for the family members of a patent application, helping users visualize the search results for the same invention produced by several offices on a single page.

How does the Patent Claims Research Dataset help in analyzing patent claims?

The dataset provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics, which can help in understanding the breadth and depth of patent claims.

What is the potential impact of a small claims patent court on patent enforcement?

A small claims patent court could provide a more streamlined and cost-effective process for resolving patent disputes, potentially affecting how patent claims are litigated and enforced.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. North Dakota Comprehensive Annual Financial Report: https://ndlegis.gov/files/committees/66-2019/21_5016_03000audit9_cafr.pdf
  5. VLSI TECHNOLOGY LLC v. INTEL CORPORATION: https://cafc.uscourts.gov/opinions-orders/22-1906.OPINION.12-4-2023_2231550.pdf

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,530,668

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Vancocin Italia MULPLETA lusutrombopag TABLET;ORAL 210923-001 Jul 31, 2018 RX Yes Yes 8,530,668 ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

Foreign Priority and PCT Information for Patent: 8,530,668

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2007-198590Jul 31, 2007
PCT Information
PCT FiledJuly 29, 2008PCT Application Number:PCT/JP2008/063541
PCT Publication Date:February 05, 2009PCT Publication Number: WO2009/017098

International Family Members for US Patent 8,530,668

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 2184279 ⤷  Try for Free 300998 Netherlands ⤷  Try for Free
European Patent Office 2184279 ⤷  Try for Free 122019000065 Germany ⤷  Try for Free
European Patent Office 2184279 ⤷  Try for Free 2019C/534 Belgium ⤷  Try for Free
European Patent Office 2184279 ⤷  Try for Free CA 2019 00038 Denmark ⤷  Try for Free
European Patent Office 2184279 ⤷  Try for Free 132019000000090 Italy ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.